Literature DB >> 8420584

The mortality experience of workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a trichlorophenol process accident.

J J Collins1, M E Strauss, G J Levinskas, P R Conner.   

Abstract

Epidemiologic studies on dioxin, specifically 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), have not consistently found an increased cancer risk. This study examines mortality rates for 754 employees at a chemical plant after an accident in 1949 in which 122 workers developed chloracne from high exposure to TCDD. We also examined exposure to 4-aminobiphenyl, a potential bladder carcinogen. Although the numbers are small, and confounding factors cannot be ruled out, workers exposed to 4-aminobiphenyl who developed chloracne from the accident had increased mortality rates from soft tissue sarcoma, bladder cancer, and respiratory cancer. All soft tissue sarcomas occurred among workers with potential 4-aminobiphenyl exposure, whereas no soft tissue sarcomas occurred among workers with TCDD exposure alone. In these workers, exposure to TCDD alone at levels great enough to cause chloracne was not associated with increased cancer rates.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420584     DOI: 10.1097/00001648-199301000-00003

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  12 in total

1.  Mortality surveillance and occupational hazards: the Solutia mortality experience 1980-94.

Authors:  J J Collins; S G Riordan
Journal:  Occup Environ Med       Date:  2000-10       Impact factor: 4.402

2.  Historical cohort study of 10 109 men in the North American vinyl chloride industry, 1942-72: update of cancer mortality to 31 December 1995.

Authors:  K A Mundt; L D Dell; R P Austin; R S Luippold; R Noess; C Bigelow
Journal:  Occup Environ Med       Date:  2000-11       Impact factor: 4.402

3.  Mortalities of workers at the Nitro plant with exposure to 2-mercaptobenzothialzole.

Authors:  J J Collins; M E Strauss; S G Riordan
Journal:  Occup Environ Med       Date:  1999-10       Impact factor: 4.402

4.  Soft tissue sarcomas of the extremities.

Authors:  Blake A Morrison
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-07

Review 5.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

6.  Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  James J Collins; Kenneth Bodner; Lesa L Aylward; Michael Wilken; Catherine M Bodnar
Journal:  Am J Epidemiol       Date:  2009-06-26       Impact factor: 4.897

7.  Mortality experience of employees exposed to 2-mercaptobenzothiazole at a chemical plant in Nitro, West Virginia.

Authors:  M E Strauss; E D Barrick; R M Bannister
Journal:  Br J Ind Med       Date:  1993-10

8.  Cadmium, carcinogen, co-carcinogen and anti carcinogen.

Authors:  R Chandra; S K Dass; P Tomar; M Tiwari
Journal:  Indian J Clin Biochem       Date:  2001-07

9.  Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers.

Authors:  J Vena; P Boffetta; H Becher; T Benn; H B Bueno-de-Mesquita; D Coggon; D Colin; D Flesch-Janys; L Green; T Kauppinen; M Littorin; E Lynge; J D Mathews; M Neuberger; N Pearce; A C Pesatori; R Saracci; K Steenland; M Kogevinas
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

10.  Association between dioxin and cancer incidence and mortality: a meta-analysis.

Authors:  Jinming Xu; Yao Ye; Fang Huang; Hanwen Chen; Han Wu; Jian Huang; Jian Hu; Dajing Xia; Yihua Wu
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.